WallStreetZenWallStreetZen

NASDAQ: XBIO
Xenetic Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

XBIO past revenue growth

How has XBIO's revenue growth performed historically?
Company
58.52%
Industry
61.36%
Market
21.91%
XBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
XBIO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

XBIO earnings and revenue history

Current Revenue
$1.6M
Current Earnings
-$6.9M
Current Profit Margin
-445.2%

XBIO Return on Equity

Current Company
-42.5%
Current Industry
-9.8%
Current Market
-9.5%
XBIO's Return on Equity (-42.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when XBIO announces earnings.

XBIO Return on Assets

Current Company
-39.6%
Current Industry
0.6%
XBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

XBIO Return on Capital Employed

Current Company
-47.59%
Current Industry
11.2%
XBIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XBIO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
XBIO$1.55M-$6.88M-$6.91M-12.83%N/A
PHIO$0.00-$12.00M-$12.20M-100.00%N/A
PTIX$0.00-$3.68M-$3.84MN/AN/A
BNTC$62.00k-$18.43M-$18.85M+12.49%N/A
ALRN$0.00-$27.16M-$27.33MN/AN/A
View Top Biotech Stocks

XBIO earnings dates

Next earnings date
Apr 3, 2023

Xenetic Biosciences Earnings & Revenue FAQ

What were XBIO's earnings last quarter?

On Invalid Date, Xenetic Biosciences (NASDAQ: XBIO) reported Q3 2022 earnings per share (EPS) of -$0.06, up 53.85% year over year. Total Xenetic Biosciences earnings for the quarter were -$804.02 thousand. In the same quarter last year, Xenetic Biosciences's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Xenetic Biosciences stock.

What was XBIO's earnings growth in the past year?

As of Q1 2023, Xenetic Biosciences's earnings has grown year over year. Xenetic Biosciences's earnings in the past year totalled -$6.91 million.

What is XBIO's earnings date?

Xenetic Biosciences's earnings date is Invalid Date. Add XBIO to your watchlist to be reminded of XBIO's next earnings announcement.

What was XBIO's revenue last quarter?

On Invalid Date, Xenetic Biosciences (NASDAQ: XBIO) reported Q3 2022 revenue of $414.25 thousand up 18.6% year over year. In the same quarter last year, Xenetic Biosciences's revenue was $349.27 thousand.

What was XBIO's revenue growth in the past year?

As of Q1 2023, Xenetic Biosciences's revenue has grown 58.52% year over year. This is 2.84 percentage points lower than the US Biotechnology industry revenue growth rate of 61.36%. Xenetic Biosciences's revenue in the past year totalled $1.55 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.